Advocacy is a core part of the work of the AHA, protecting and sustaining what hospitals and health systems need to truly care for our communities. We often hear about legislative and regulatory advocacy, but legal advocacy is another important part of these efforts, both in and outside the courts.

Chad Golder, general counsel at the AHA, recently joined me on the Leadership Dialogue for a conversation on our current legal environment, what the AHA is doing on behalf of members, and what hospital and health system leaders can do to help. 

We discuss a number of issues, including:

  • The 340B Drug Pricing Program, a crucial lifeline for eligible hospitals to manage rising prescription drug costs and ensure our patients and communities have access to the health care services they need.
  • Regulatory relief to address regulations that foster anticompetitive conduct by insurers and limit the ability of hospitals and health systems to thrive in a competitive free market.
  • The many legal challenges to actions the Trump administration has undertaken.
  • Potential implications of a Supreme Court decision last year overturning the Chevron doctrine, which required courts to defer to federal agencies to interpret ambiguous laws. 

I hope you find our conversation insightful and strategic. Look for future conversations with health care, business and community leaders on making health better as part of the Chair File in 2025.

* Note that this conversation was recorded on June 10, 2025.
 

 

 

Related News Articles

Headline
The House Appropriations Committee today released bill text for a continuing resolution to fund the government through Nov. 21. The bill also extends key…
Headline
The AHA commented Sept. 15 on the Centers for Medicare & Medicaid Services calendar year 2026 outpatient prospective payment system and ambulatory surgical…
Headline
The United States Court of Appeals for the Fifth Circuit Sept. 12 affirmed a Mississippi Court’s decision to deny AbbVie’s request for a preliminary injunction…
Headline
Newsweek’s Access Health newsletter today features a conversation with AHA Chair Tina Freese Decker, president and CEO of Corewell Health in Michigan, where…
Headline
The AHA Sept. 8 urged the Federal Trade Commission and Antitrust Division of the Department of Justice to investigate several drug companies’ concerted efforts…
Perspective
Public
Congress returns to Washington, D.C., this week facing a long list of things to do, including several that will impact hospitals’ ability to provide access to…